David Hoffmann
Director/Board Member at MOLECULAR TEMPLATES, INC.
Net worth: - $ as of 30/03/2024
Profile
David R.
Hoffmann is currently the Chief Executive Officer at Hoffmann Associates.
He is also serving as an Independent Director at Molecular Templates, Inc. and Molecular Templates OpCo, Inc. Mr. Hoffmann has previously held positions as a Director at Therapeutic Discovery Corp., Crescendo Pharmaceuticals Corp., Alza Development Corp., DURECT Corp., and Threshold Pharmaceuticals, Inc. He also served as the Treasurer & Vice President at ALZA Corp.
from 1992 to 2002.
Mr. Hoffmann completed his undergraduate degree at The University of Colorado.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/10/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
David Hoffmann active positions
| Companies | Position | Start |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Director/Board Member | 31/07/2017 |
Hoffmann Associates
 Hoffmann Associates Engineering & ConstructionIndustrial Services Hoffmann Associates provides architectural services for homes, remodels, additions, and kitchen renovations. The company was founded in 1993 and is headquartered in Boulder, CO. | Chief Executive Officer | - |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Director/Board Member | - |
Former positions of David Hoffmann
| Companies | Position | End |
|---|---|---|
| DURECT CORPORATION | Chairman | 16/03/2023 |
| ALZA CORPORATION | Director of Finance/CFO | 31/12/1991 |
Therapeutic Discovery Corp.
 Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | - |
| Alza Development Corp. | Director/Board Member | - |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Director/Board Member | - |
Training of David Hoffmann
| The University of Colorado | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| DURECT CORPORATION | Health Technology |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Crescendo Pharmaceuticals Corp.
 Crescendo Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Crescendo Pharmaceuticals Corp. develops pharmaceutical products. The company is headquartered in Mountain View, CA. | Health Technology |
| Alza Development Corp. | |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
Hoffmann Associates
Hoffmann Associates Engineering & ConstructionIndustrial Services Hoffmann Associates provides architectural services for homes, remodels, additions, and kitchen renovations. The company was founded in 1993 and is headquartered in Boulder, CO. | Industrial Services |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Stock Market
- Insiders
- David Hoffmann
